Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 16;34(5):1100–1106. doi: 10.3904/kjim.2017.226

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Korean Association of Internal Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Clinical outcomes of fulvestrant in postmenopausal women previously treated with endocrine therapy (n = 84). (A) Progression-free survival (PFS) of patients treated with fulvestrant (median PFS, 4.4; 95% confidence interval [CI], 3.4 to 5.5 months), (B) overall survival (OS) of patients treated with fulvestrant (median OS, 32.5; 95% CI, 17.6 to 47.4 months).